8:22 AM
Leo Group India
| ||
| Could A Fish Oil Backlash Wash Out Amarin Pharmaceuticals? Forbes Amarin Pharmaceuticals has been a biotech success story. Over the past two years the share price has tripled as the tiny company has managed to get approval from the Food and Drug Administration for Vascepa, a fish-oil pill that in many ways seems set ... See all stories on this topic » | ||
| Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase ... Sacramento Bee MONTREAL, Nov. 19, 2012 -- /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that its board of directors has authorized a new securities repurchase program (the "Securities Repurchase Program"). See all stories on this topic » | ||
| Biostar Pharmaceuticals, Inc. Announces 2012 Third Quarter Financial Results Sacramento Bee 19, 2012 -- /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today ... See all stories on this topic » | ||
| Validus Pharmaceuticals Now Exclusively Marketing Six Established U.S. ... Sacramento Bee PARSIPPANY, N.J., Nov. 19, 2012 -- /PRNewswire/ -- Validus Pharmaceuticals together with Wood Creek Capital Management, LLC announced today the acquisition of the U.S. rights to six well-known product lines from Novartis Pharmaceuticals Corporation ... See all stories on this topic » | ||
| Alexza Pharmaceuticals Receives Updated Day 180 List of Outstanding Issues ... Sacramento Bee 19, 2012 -- /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has received a CHMP (Committee for Medicinal Products for Human Use) Day 180 Second List of Outstanding Issues (LoOI) from the European Medicines ... See all stories on this topic » | ||
| Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 ... Sacramento Bee The Asia-Pacific active pharmaceutical ingredients market revenue held a share of around 28.3% of the global API market in 2011, with the global revenue standing at $108,613m. Total revenue generated by the Asia-Pacific API market was $30,693m in 2011 ... See all stories on this topic » | ||
| ACETO Subsidiary, Rising Pharmaceuticals, to Launch First Generic Version of ... MENAFN.COM PORT WASHINGTON, N.Y., Nov 19, 2012 (Menafn - GlobeNewswire via COMTEX) --ACETO Corporation ACET, a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, ... See all stories on this topic » | ||
| LIGAND PHARMACEUTICALS INC. : Ligand Partner GlaxoSmithKline Receives ... 4-traders Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment